Feed TCRT
Summary
15 / 100 · Bulios Score
Valuation 0Growth 0Profitability 0Quality 0Debt 74Stability 29
What speaks for it
- It has no debt and holds $124.0K in cash.
- It beat profit estimates 7 times in the last 8 quarters.
What to watch
- Revenue fell by 88% a year over the last 3 years.
- The company made a loss over the last 12 months.
- It passes only 1 of the 9 points of the Piotroski financial health test.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks expensiveThe company made a loss over the last 12 months, so there is no profit to set the price against.
Valuation in detailIs it growing?
It is shrinkingRevenue (USD)
2021202220232024202520262027
Diluted EPS (USD)
2021202220232024202520262027
- Analyst estimate
Revenue fell by 88% a year over the last 3 years.
Growth in detailDoes it make money?
PoorlyOver the last 12 months it made a loss of $4.01M.
Profitability in detailIs it financially healthy?
YesCash and short-term investments $124.0K
Debt $0.00
Free cash flow over 12 months -$2.82M
It has no debt.
Financial health in detailDoes it pay a dividend?
NoIt pays no dividend.
Dividends in detailWhat do analysts expect?
Neutral- Buy 1
- Hold 8
- Sell 1
No analyst has published a price target.
10% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
By product
The company reports no revenue by product.
By region
The company reports no revenue by region.